Navigation Links
DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
Date:9/12/2013

FREMONT, Calif., Sept. 12, 2013 /PRNewswire/ -- DiscoveRx Corporation, through its BioSeek division, today announced the release of an industry-first, primary human cell-based assay platform for oncology research. Consisting of primary human cell-based tumor-host model systems, this new BioMAP panel enables researchers to easily assess the phenotypic impact of candidate compounds on tumor microenvironment biology to better predict in vivo drug activities and forecast potential clinical outcomes with respect to drug efficacy and safety.

(Logo: http://photos.prnewswire.com/prnh/20130912/SF78575LOGO)

"These oncology-focused BioMAP® systems will support predictive and physiologically relevant cancer compound development from early discovery through pre-clinical development stages," said Ellen Berg, Ph.D., Scientific Director and General Manager of BioSeek. "They capture human tumor-host activities that can be modulated by a number of clinically relevant mono-therapies as well as drug combinations involving small molecule chemotherapeutics and biologics. Such BioMAP® models recapitulate complex interactions between tumor cells, stromal and/or vascular tissue and recruited, infiltrating immune cells to the tumor."

Despite a fair number of cancer drugs gaining approval for clinical use, late-stage compound attrition still remains a major issue in anticancer drug development. A critical need remains for pre-clinical models that can serve as better predictors of success in clinical trials. Scientific evidence is mounting that combination therapies using previously approved oncology drugs can be more efficacious, safe and successful than traditional mono-therapies, making the need for predictive in-vivo models more apparent. By virtue of the fact that the two compounds selected for combination therapy would have been developed independently, determining the appropriate therapeutic dosing for such combinations also continues to be technically challenging. The ability to test drug combinations in predictive models such as BioMAP can support the testing of pre-clinical strategies involving both development compounds and approved drugs.

For pricing inquiries, request for collaboration and project proposals, please send an email to busdev@bioseekinc.com.

About BioMAP

BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative activity profiles of each potential drug, assisting in the selection and development of new drug candidates. For more information on BioMAP drug discovery services, visit http://www.biomapsystems.com.

About DiscoveRx

Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in Fremont, California, with additional offices in San Diego, CA, San Francisco, CA and Birmingham, England. DiscoveRx is a leading provider of next generation proprietary platforms for both target-based and phenotypic based drug discovery. The company holds extensive intellectual property for its core technology platforms 1) PathHunter®, HitHunter®and  InCELL Hunter™ : β-galactosidase based enzyme fragment complementation, 2) KINOMEscan® : in vitro binding assay platform and 3) BioMAP®: A three part drug discovery solution consisting of BioMAP system, proprietary database, and predictive analytics tools. Utilizing these proprietary platforms, DiscoveRx has developed and commercialized industry leading panels of over 1000 target based and primary cell based assay solutions for Oncology, Metabolic Disease, Inflammation, CNS and Cardiovascular drug discovery research. Many of DiscoveRx's innovative solutions have been widely adopted in pharmaceutical, biotechnology and academic laboratories worldwide. For more information, visit www.discoverx.com


'/>"/>
SOURCE DiscoveRx Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Entomological Society of America announces 2013 awardees
2. Entomological Foundation announces 2013 Insect Science Award winners
3. Chair Mats of Glass Company Clearly Innovative Announces the Launch of 20 New Dealers in the Midwest
4. Diamond Vision Announces New and Generous Promotion on its iLASIK in NYC Procedure
5. Physiotherapy in Singapore Clinic Urbanrehab Pte Ltd Announces the Opening of an Additional Location
6. Elsevier announces the launch of a new open access journal: Water Resources and Industry
7. NOAA announces additions to National System of Marine Protected Areas
8. FASEB announces BioArt image and video competition winners
9. Entomological Society of America announces 2013 fellows
10. Neurotechnology Announces NCheck Bio Attendance 2.0 Biometric Time and Attendance Software
11. Bert L. & N. Kuggie Vallee Foundation announces first recipients of its Young Investigator Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology: